Bronchial Asthma With eNO-levels Greater Than 30 ppB
Conditions
Keywords
Asthma, Sputum, Blood, Inflammation, adaptive immune system, innate immune system
Brief summary
The aim of this case-control study is the comparison of the cell distribution in induced sputum in young adults with asthma and in healthy controls. The study consists of two visits. At both visits subjects are asked to perform a lung function test (body plethysmography) and levels of exhaled nitric oxide (eNO) are measured. At the first visit a blood sample is drawn to determine the inflammatory and allergic status of the subjects and the sputum is induced by an ultrasonic nebulizer. At the second visit another sputum sample is induced by a nozzle nebulizer. The cell distribution will be evaluated in both sputum samples.
Detailed description
Objectives: The aim of this study is the characterization of healthy children/ young adults and matched patients with asthma in terms of lung function, and the degree of the systemic and bronchial inflammation. Sputum and serum samples are analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and by a cytometric bead assay (CBA). Components of the innate immune system (mannose-binding protein, TLR recognition proteins and surfactant proteins) are determined from sputum or blood respectively. Methods and Work Programme: This study consists of two study visits (V1 and V2) V1 (day 0 - duration 1 hour): * Measurement of exhaled nitric oxide (eNO) * Lung function testing with and body plethysmography * Blood test: blood count, CRP, RAST, serum inflammatory mediators, markers of the non-specific pulmonary defense system * Induced sputum attained by an ultrasonic-nebulizer for inflammatory mediators and microbiological investigations V2 (day 14-28 - duration 1 hour): * Measurement of nitric oxide in expired air (eNO) * Lung function testing with spirometry and body plethysmography * Induced sputum attained by a nozzle-nebulizer for inflammatory mediators and microbiological investigations Study population: Children, adolescents and young people (6 - 25 years of age). Both the patients and the healthy subjects are recruited from the outpatient clinic of Pediatric Allergy and Pulmonology.
Interventions
None listed
Sponsors
Johann Wolfgang Goethe University Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
6 Years to 25 Years
Healthy volunteers
Yes
Inclusion criteria
* informed consent * between 6 and 25 years of age * Known bronchial asthma/no bronchial asthma(depending on the study group) * Ability to perform lung function tests and inhalation
Exclusion criteria
* \< 6 and \> 25 years of age * Any acute condition with systemic or bronchial inflammation * any chronic condition or infection (e.g. HIV, tuberculosis, malignancy) * pregnancy * known alcohol and/ or drug abuse * Inability to understand the extent and scope of the study * Participation in another study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| cell count differences in induced sputum | V1 and V2 respectively (V1 (day 0 - duration 1 hour) V2 (day 14-28 - duration 1 hour) | Differences in neutrophils, macrophages and lymphocytes in subjects with and without asthma |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| differences in cell count depending on the method of sputum induction | V1 and V2 respectively (V1 (day 0 - duration 1 hour) V2 (day 14-28 - duration 1 hour) | At V1 an ultrasonic nebulizer is used for sputum induction. At V2 a breath controlled nozzle nebulizer is used for sputum induction. These different techniques might lead to different cell counts in included subjects. |
Countries
Germany
Outcome results
None listed